Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cidara Therapeutics (CDTX) Asset Utilization Ratio: 2019-2025

Historic Asset Utilization Ratio for Cidara Therapeutics (CDTX) over the last 4 years, with Mar 2025 value amounting to 0.06.

  • Cidara Therapeutics' Asset Utilization Ratio fell 85.05% to 0.06 in Q1 2025 from the same period last year, while for Mar 2025 it was 0.06, marking a year-over-year decrease of 85.05%. This contributed to the annual value of 0.01 for FY2024, which is 97.77% down from last year.
  • As of Q1 2025, Cidara Therapeutics' Asset Utilization Ratio stood at 0.06, which was down 64.80% from 0.17 recorded in Q2 2024.
  • Over the past 5 years, Cidara Therapeutics' Asset Utilization Ratio peaked at 1.19 during Q1 2023, and registered a low of 0.06 during Q1 2025.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.64 (2023), whereas its average is 0.59.
  • In the last 5 years, Cidara Therapeutics' Asset Utilization Ratio soared by 441.15% in 2021 and then slumped by 85.05% in 2025.
  • Quarterly analysis of 5 years shows Cidara Therapeutics' Asset Utilization Ratio stood at 0.71 in 2021, then soared by 47.68% to 1.05 in 2022, then slumped by 37.51% to 0.66 in 2023, then slumped by 83.06% to 0.17 in 2024, then plummeted by 85.05% to 0.06 in 2025.
  • Its Asset Utilization Ratio stands at 0.06 for Q1 2025, versus 0.17 for Q2 2024 and 0.40 for Q1 2024.